-
EdU Imaging Kits (Cy5) for PAH Research
2026-09-15
EdU Imaging Kits (Cy5) translate S-phase DNA synthesis into an actionable readout for pulmonary arterial endothelial cell studies, including hypoxia and MMP8 perturbation models. The click-chemistry workflow supports both morphology-preserving microscopy and quantitative flow cytometry while avoiding the DNA denaturation required by conventional BrdU assays.
-
Mouse Neutrophil Cell Isolation Kit for Functional Assays
2026-09-15
The Mouse Neutrophil Cell Isolation Kit supports high-purity, minimally perturbed neutrophil preparation for mechanistic immunology. This guide presents a compartment-aware workflow that connects negative selection with rigorous testing of neutrophil-targeted mRNA nanotherapies.
-
Chlorambucil Assays: From DNA Damage to Cell Death
2026-09-14
Chlorambucil research is more informative when DNA damage, growth arrest, and cell death are measured as related but distinct responses. This guide translates a key in vitro cancer-response framework into practical assay decisions for leukemia, glioma, and comparative cytotoxicity studies.
-
Cy3-dCTP Workflows for Fluorescent DNA Labeling
2026-09-14
Cy3-dCTP enables direct fluorescent incorporation into DNA and cDNA for PCR, Nick Translation, hybridization, and blot-based detection. This guide pairs practical labeling workflows with an evidence-aware interpretation of ordered DNA frameworks, helping researchers improve signal while controlling incorporation bias and probe quality.
-
Phenytoin Workflows for Sodium Channel Research
2026-09-13
Phenytoin supports controlled sodium channel modulation research, from whole-cell electrophysiology to mechanistic assays in neurological disease models. This guide connects practical compound handling with a reference study showing concentration-dependent, noncompetitive inhibition of human paraoxonase-1, helping researchers separate channel effects from enzyme-level liabilities.
-
LY2109761: TGF-β Signaling Workflow Guide
2026-09-12
LY2109761 provides a practical way to interrogate receptor-proximal TGF-β biology across fibrosis, tumor invasion, and radiation-response assays. This guide translates the HMrSV5 mesothelial-cell study into reproducible workflows, control strategies, and troubleshooting decisions for pathway-focused research.
-
CA-074 Workflow for Cathepsin B Research
2026-09-12
CA-074 enables selective interrogation of cathepsin B in lysosomal membrane permeabilization, necroptosis, cancer metastasis, neurotoxicity, and immune signaling. This workflow connects mechanistic imaging with dose-response, orthogonal validation, and troubleshooting strategies for more reproducible experiments.
-
Cefiderocol Against Resistant Pseudomonas and Acinetobacter
2026-09-11
Santerre Henriksen and colleagues directly compared cefiderocol with β-lactam/β-lactamase inhibitor combinations across a large European collection of non-fermenting Gram-negative isolates, including meropenem-resistant strains. The study found consistently high cefiderocol susceptibility in Pseudomonas aeruginosa and Acinetobacter spp., while genomic analyses identified distinct resistance-associated patterns that support parallel susceptibility testing.
-
From Fluo-4 AM to Adaptive Retinal Prostheses
2026-09-11
Fluo-4 AM connects real-time intracellular calcium concentration measurement with the mechanistic validation of emerging bioelectronic systems. This thought-leadership perspective examines how calcium imaging can complement electrophysiology and behavioral testing in the translation of adaptive retinal prostheses.
-
Sodium Dicloxacillin Monohydrate: Assay to Action
2026-09-10
Sodium dicloxacillin monohydrate is examined here through a measurement-centered framework linking PBP inhibition, MSSA models, compartment-specific potency, and analytical quality control. The article also explains how selective spectrophotometry can guide practical assay selection without overstating what the evidence proves.
-
YAP–TEAD Super-Enhancers in Surface Ectoderm
2026-09-10
The reference study maps how super-enhancer architecture and YAP–TEAD activity coordinate early surface ectoderm commitment from pluripotent stem cells. Its combination of 3D genome profiling, targeted enhancer perturbation, and transcription-factor analysis links noncoding regulatory elements to lineage progression and provides a framework for studying epithelial regeneration.
-
ECL Western Blotting Substrate: Practical Guide
2026-09-09
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP-linked Western blot workflows using X-ray film or CCD imaging, not for fluorescent or radioisotopic assays, and the prepared reagent should be used promptly.
-
PRINT: RNA-Mediated Safe-Harbor Transgene Insertion
2026-09-09
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins and target-primed reverse transcription to insert transgenes at a multicopy human safe-harbor locus. Its reported efficiency, direct genomic cDNA synthesis, and absence of donor DNA establish a mechanistically distinct alternative to conventional CRISPR repair and viral delivery, while leaving important questions about cargo range, cell-type transferability, and long-term genome behavior.
-
SB203580 and p38α: Assay Logic Beyond Inhibition
2026-09-08
SB203580 is more than an ATP-competitive p38 MAPK inhibitor: it is a tool for separating kinase output from activation-loop phosphorylation and phosphatase control. This guide translates recent p38α conformational research into practical assay design, controls, and interpretation strategies.
-
tiRNA: Controllable Gene Silencing by Translation Inhibition
2026-09-08
The reference study introduces translation inhibition RNA (tiRNA), an aptamer-based steric-blocking design that suppresses selected mRNA translation without degrading the transcript. Its modular targeting strategy, siRNA-comparable activity, and neutralizing-strand reversibility suggest a controllable framework for regulating proteins whose expression must be reduced temporarily or selectively.